$CALM

Maine Foods Q1 fiscal 2027 earnings loss

Cal-Maine Foods reported a Q1 2027 net loss of $58.6M, down from a $199.3M profit a year earlier, due to lower egg prices and sales. Net sales fell 41.5% to $539.6M. CEO Sherman Miller cited industry overproduction. Shares dropped 3.4% to $66.22. The company settled a price-rigging allegation earlier this year.

Original reporting
Published Sep 30, 2026, 5:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 5:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Maine Foods Q1 fiscal 2027 earnings loss — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

The loss underscores the impact of oversupply on commodity‑type food producers and may trigger re‑rating of related stocks.

02

Market read

The earnings miss and share decline provide a clear short‑term trade signal for CALM and may influence sentiment toward other egg producers.

03

What to watch

Potential cost reductions from feed price stabilization and the settlement with the Justice Department may limit further downside.

Relevance 8/10Novelty 8/10Timing: intraday today

Background

Cal-Maine Foods is the largest U.S. egg producer; its earnings are a bellwether for the broader egg and poultry sector.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

Cal-Maine Foods reported a Q1 fiscal 2027 net loss of $58.6 million and a 3.4% share drop, marking the first public disclosure of its earnings decline.

Expected impact

likely further pressure as investors price in weaker demand and no dividend

Evidence & confidence

Losses are large relative to prior profit, margins collapsed, and the stock already fell 3.4% on the news.

Market effects

Egg producers may face pricing pressure as oversupply persists, potentially affecting related agribusiness stocks.

U.S. consumer staples sector could see modest weakness from the egg market downturn.

Limited to U.S. poultry and food‑production markets; no broader macro impact.

Counterpoint

If flock growth truly cools, future earnings could rebound, making the current dip a buying opportunity.

Key entities

  • Sherman Miller

    President and CEO of Cal-Maine Foods, provided commentary on market conditions.

Related articles

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CALMHighAI 8/10

Cal-Maine (CALM) Stock Trades Down, Here Is Why

Cal-Maine Foods (CALM) reported a Q3 2026 net loss, with net sales down 41.5% YoY to $539.6M, missing estimates. Gross profit fell to $403K, and the company posted a net loss of $58.6M. CEO Sherman Miller attributed results to industry supply imbalance. Shares fell 3%, trading at $66.49.

$CALMMedAI 8/10

Cal-Maine Foods Q1 2027 Earnings Call: Complete Transcript - Cal-Maine Foods (NASDAQ:CALM)

Cal-Maine Foods (NASDAQ:CALM) reported Q1 FY2027 net sales down 41.5% to $539.6M and a net loss of $58.6M. The company faces pressure from an oversupplied egg market but is expanding specialty eggs and prepared foods. It plans a 60% increase in prepared foods capacity by H1 FY2028 and has $767.6M in cash. Management repurchased $14.9M in shares post-quarter, focusing on long-term growth.